A Review Of different sources of APIs
“The adoption of State-of-the-art producing technologies could pose a problem to the current regulatory framework simply because most restrictions were developed according to classic batch production strategies under a unified pharmaceutical quality method,” explained Woodcock in her testimony. “Therefore, FDA has introduced an hard work to d